BeStock  

Cardinal Health CAH

$272.81 +$0.47 (+0.17%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $272.81 0.00%
Open$276.52
Prev close$272.34
Day range$271.98 – $277.72
Volume1.98M
Market cap$63.06B
P/E (TTM)35.3
Dividend yield0.75%

Fundamentals

Latest reported quarter: Q1, ended Sep 2026

Revenue$67.51B+5.5% YoY
Operating profit$819.00M+8.6% YoY
Net profit$556.00M+22.5% YoY
Diluted EPS$2.38+26.6% YoY
Free cash flow$1.24B+43.5% YoY
Operating cash flow$1.40B

Revenue, last 8 quarters

$55.3BDec '24$54.9BMar '25$60.2BJun '25$64.0BSep '25$65.6BDec '25$60.9BMar '26$63.7BJun '26$67.5BSep '26

Net profit, last 8 quarters

$401.0MDec '24$508.0MMar '25$243.0MJun '25$454.0MSep '25$471.0MDec '25$380.0MMar '26$400.0MJun '26$556.0MSep '26

Diluted EPS by quarter

1.65Dec '242.10Mar '251.00Jun '251.88Sep '251.97Dec '251.69Mar '261.70Jun '262.38Sep '26

Free cash flow by quarter

$-495.0MDec '24$2.8BMar '25$1.3BJun '25$865.0MSep '25$555.0MDec '25$1.7BMar '26$1.4BJun '26$1.2BSep '26

Annual revenue

$162.5BFY21$181.3BFY22$205.0BFY23$226.8BFY24$222.6BFY25$254.2BFY26

Profitability & balance sheet

Gross margin3.9%
Operating margin1.3%
Net margin0.7%
Return on assets3.2%
Current ratio0.88
Liabilities / assets104.8%
Cash & investments$5.26B
Total debt$8.82B
Net cash (debt)-$3.55B
Free cash flow / sales1.9%

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Pharmaceutical and Specialty Solutions$62.58B 92.7%
  • Global Medical Products and Distribution (GMPD)$3.19B 4.7%
  • Other$1.76B 2.6%

SEC annual financial snapshot

Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 17:51 UTC.

MetricUSDBasisPeriod endFiled / SEC source
Revenue$254.25BAnnual2026-06-302026-08-11
Net income$1.71BAnnual2026-06-302026-08-11
Operating cash flow$5.17BAnnual2026-06-302026-08-11
Total assets$57.30BPeriod end2026-06-302026-08-11
Stockholders’ equity-$2.88BPeriod end2026-06-302026-08-11
Cash and cash equivalents$4.86BPeriod end2026-06-302026-08-11

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Revenue as Reported $67.51B $254.25B $63.67B $60.94B $65.63B
Total Operating Revenue $67.51B $254.25B $63.67B $60.94B $65.63B
Cost of Revenue $64.92B $244.47B $61.11B $58.44B $63.23B
Gross Profit $2.60B $9.77B $2.56B $2.50B $2.40B
Operating Expense $1.78B $6.60B $1.75B $1.66B $1.63B
Selling and Admin Expenses $1.60B $6.13B $1.63B $1.54B $1.50B
Depreciation & Amortization & Depletion $182.00M $469.00M $121.00M $114.00M $130.00M
-Depreciation & Amortization $182.00M $469.00M $121.00M $114.00M $130.00M
Operating Profit $819.00M $3.17B $814.00M $842.00M $763.00M
Net Non-Operating Interest Income (Expense) -$73.00M -$348.00M -$79.00M -$101.00M -$88.00M
Non-Operating Interest Expense $73.00M $348.00M $79.00M $101.00M $88.00M
Other Income (Expense) -$58.00M -$651.00M -$181.00M -$349.00M -$45.00M
Special Income (Charges) -$64.00M -$682.00M -$207.00M -$333.00M -$56.00M
-Less:Restructuring and Mergern & Acquisition $117.00M $393.00M $84.00M $137.00M $88.00M
-Less:Impairment of Capital Assets -$4.00M – – $185.00M –
-Less:Other Special Charges -$47.00M -$10.00M -$3.00M $11.00M -$18.00M
-Less:Write Off -$2.00M $299.00M – – -$14.00M
Other Non-Operating Income (Expenses) $6.00M $31.00M $26.00M -$16.00M $11.00M
Pretax Profit $688.00M $2.17B $554.00M $392.00M $630.00M
Tax $132.00M $469.00M $154.00M $12.00M $159.00M
Net Profit $556.00M $1.71B $400.00M $380.00M $471.00M
Profit from Continuing Operations $556.00M $1.71B $400.00M $380.00M $471.00M
Minority Interests $2.00M -$9.00M $2.00M -$19.00M $4.00M
Net Income to Parent Company $554.00M $1.71B $398.00M $399.00M $467.00M
Net Income to Common Stockholders $554.00M $1.71B $398.00M $399.00M $467.00M
Basic EPS $2.39 $7.27 $1.70 $1.69 $1.98
Diluted EPS $2.38 $7.23 $1.70 $1.69 $1.97
Dividend Per Share $0.52 $2.05 $0.52 $0.51 $0.51

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $59.54B $57.30B $57.30B $56.69B $58.08B
Total Current Assets $40.99B $38.75B $38.75B $38.06B $39.23B
Cash and Cash Equivalents & Short-Term Investments $5.26B $4.86B $4.86B $3.94B $2.78B
-Cash and Cash Equivalents $5.26B $4.86B $4.86B $3.94B $2.78B
Receivables $14.54B $13.82B $13.82B $13.65B $13.66B
-Accounts Receivable $14.54B $13.82B $13.82B $13.65B $13.66B
Inventory $18.40B $17.30B $17.30B $18.01B $20.12B
Other Current Assets $2.78B $2.76B $2.76B $2.47B $2.68B
Total Non-Current Assets $18.55B $18.55B $18.55B $18.63B $18.85B
Net PPE $3.00B $3.03B $3.03B $2.93B $2.88B
Goodwill and Other Intangible Assets $13.69B $13.63B $13.63B $13.70B $13.98B
-Goodwill $11.54B $11.44B $11.44B $11.42B $11.61B
-Other Intangible Assets $2.15B $2.19B $2.19B $2.28B $2.37B
Other Non-Current Assets $1.87B $1.88B $1.88B $2.00B $2.00B
Total Liabilities $62.41B $60.02B $60.02B $59.36B $60.78B
Total Current Liabilities $46.33B $43.90B $43.90B $41.99B $43.31B
Payables $40.94B $38.28B $38.28B $37.83B $39.00B
-Accounts Payable $40.94B $38.28B $38.28B $37.83B $39.00B
Current Accrued Expenses $3.50B $3.74B $3.74B $3.48B $3.64B
Short-Term Debt and Capital Lease Obligation $1.89B $1.88B $1.88B $671.00M $680.00M
-Current Debt $1.89B $1.88B $1.88B $671.00M $680.00M
Total Non-Current Liabilities $16.08B $16.12B $16.12B $17.37B $17.47B
Long Term Debt and Capital Lease Obligation $6.93B $7.00B $7.00B $8.25B $8.35B
-Long Term Debt $6.93B $7.00B $7.00B $8.25B $8.35B
Other Non-Current Liabilities $9.16B $9.12B $9.12B $9.13B $9.12B
Total Equity -$2.87B -$2.72B -$2.72B -$2.67B -$2.70B
Stockholders' Equity -$3.03B -$2.88B -$2.88B -$2.83B -$2.88B
Capital Stock $2.77B $2.89B $2.89B $2.82B $2.85B
-Common Stock $2.77B $2.89B $2.89B $2.82B $2.85B
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Retained Earnings $2.44B $2.01B $2.01B $1.73B $1.46B
Less: Treasury Stock -$8.08B -$7.61B -$7.61B -$7.22B -$7.03B
Gains/Losses Not Affecting Retained Earnings -$159.00M -$165.00M -$165.00M -$161.00M -$153.00M
Minority Interests $159.00M $159.00M $159.00M $160.00M $184.00M
-Gross PPE – $7.97B $7.97B – –
-Accumulated Depreciation – -$4.94B -$4.94B – –

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow $1.40B $5.17B $1.69B $1.82B $686.00M
Net cash flow from continuing operations $1.40B $5.17B $1.69B $1.82B $686.00M
Net Income from Continuing Operations $556.00M $1.71B $400.00M $380.00M $471.00M
Depreciation & Depletion & Amortization $247.00M $956.00M $241.00M $248.00M $234.00M
Change in Working Capital $462.00M $1.66B $748.00M $846.00M -$106.00M
-Change in Receivables -$734.00M -$408.00M -$193.00M -$17.00M $341.00M
-Change in Inventory -$1.17B -$488.00M $697.00M $2.09B -$2.54B
-Change in Payables and Accrued Expense $2.37B $2.60B $262.00M -$1.23B $2.10B
-Change in Other Current Liabilities -$4.00M -$45.00M -$18.00M -$5.00M -$6.00M
Net cash flow from investing -$251.00M -$2.58B -$281.00M -$181.00M -$1.98B
Net Cash Flow from Continuing Investing Activities -$251.00M -$2.58B -$281.00M -$181.00M -$1.98B
Net PPE Purchase and Sale -$142.00M -$618.00M -$264.00M -$146.00M -$100.00M
Net Business Purchase and Sale -$149.00M -$1.99B -$24.00M -$42.00M -$1.88B
Net Investment Purchase and Sale $34.00M $28.00M $1.00M $27.00M -$9.00M
Net Other Investing Changes $6.00M -$3.00M $6.00M -$20.00M $13.00M
Financing Cash Flow -$742.00M -$1.60B -$490.00M -$483.00M -$519.00M
Net Cash Flow from Continuing Financing Activities -$742.00M -$1.60B -$490.00M -$483.00M -$519.00M
Net Issuance Payments Of Debt -$11.00M $337.00M -$17.00M -$111.00M -$12.00M
Net Common Stock Issuance -$500.00M -$1.36B -$350.00M -$250.00M -$383.00M
Cash Dividends Paid -$126.00M -$491.00M -$120.00M -$120.00M -$122.00M
Net Other Financing Charges -$105.00M -$90.00M -$3.00M -$2.00M -$2.00M
Ending Cash Balance $5.26B $4.86B $4.86B $3.94B $2.78B
Net Change in Cash $405.00M $988.00M $921.00M $1.16B -$1.81B
Beginning Cash Balance $4.86B $3.87B $3.94B $2.78B $4.59B
Effect of Exchange Rate Changes $3.00M -$6.00M -$2.00M $1.00M -$3.00M
Free Cash Flow $1.24B $4.53B $1.43B $1.68B $555.00M
Deferred Tax – $91.00M – – –

Discussion

No comments yet — be the first to weigh in on CAH.

Sign in to join the discussion.

Scroll to Top